Chemotherapy for advanced gastric cancer: across the years for a standard of care
@article{Scartozzi2007ChemotherapyFA, title={Chemotherapy for advanced gastric cancer: across the years for a standard of care}, author={M. Scartozzi and E. Galizia and L. Verdecchia and R. Berardi and S. Antognoli and S. Chiorrini and S. Cascinu}, journal={Expert Opinion on Pharmacotherapy}, year={2007}, volume={8}, pages={797 - 808} }
Chemotherapy is of crucial importance in advanced gastric cancer patients, in order to obtain palliation of symptoms and improve survival. The most extensively studied drugs as single agents are 5-fluorouracil, cisplatin, doxorubicin, epirubicin, mitomycin C and etoposide. Newer chemotherapeutic agents include the taxanes (docetaxel and paclitaxel), oral fluoropyrimidines (capecitabine and S-1), oxaliplatin and irinotecan. Randomised trials comparing monotherapy with combination regimens have… CONTINUE READING
Topics from this paper
46 Citations
Phase I/II studies of combination chemotherapy with S-1 and platinum in patients with previously untreated metastatic or recurrent gastric cancer
- Medicine
- Gastric Cancer
- 2008
- 1
- PDF
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
- Medicine
- Cancer Chemotherapy and Pharmacology
- 2012
- 6
- PDF
Phase II study of sunitinib as second-line treatment for advanced gastric cancer
- Medicine
- Investigational New Drugs
- 2010
- 172
- PDF
Short-term efficacy of different chemotherapy regimens in the treatment of advanced gastric cancer: a network meta-analysis
- Medicine
- Oncotarget
- 2017
- 13
- PDF
Factors predicting outcome for advanced gastroesophageal cancer in elderly patients receiving palliative chemotherapy.
- Medicine
- Clinical oncology (Royal College of Radiologists (Great Britain))
- 2010
- 15
Long Term Follow up of Patients with Advanced Cancers after Chemotherapy and Traditional Medicine (82 Cases)
- Medicine
- 2018
- 1
- PDF
TREATMENT OF PATIENTS WITH ADVANCED CANCER FOLLOWING CHEMOTHERAPY AND TRADITIONAL MEDICINE - LONG TERM FOLLOW UP OF 75 CASES
- Medicine
- 2018
- 1
- PDF
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
- Medicine
- Cancer Chemotherapy and Pharmacology
- 2010
- 13
- PDF
Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
- Medicine
- European journal of pharmacology
- 2008
- 61
References
SHOWING 1-10 OF 86 REFERENCES
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1994
- 102
Palliative chemotherapy for advanced gastric cancer.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2004
- 164
A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
- Medicine
- British Journal of Cancer
- 2004
- 80
Phase II Study of Paclitaxel and Carboplatin in Patients With Advanced Gastric Cancer
- Medicine
- American journal of clinical oncology
- 2003
- 59
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.
- Medicine
- Annals of internal medicine
- 1980
- 318
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1992
- 281
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2001
- 159
Oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. Final results of a multicenter phase II trial.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2006
- 4